Status:

RECRUITING

Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour

Lead Sponsor:

Jena University Hospital

Collaborating Sponsors:

Ruhr University of Bochum

Interdisciplinary Center of Clinical Research of the Medical Faculty Jena

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

8-18 years

Brief Summary

Introduction: Fetal exposure to glucocorticoids (GCs) used to induce fetal lung maturation in women threatened by premature labour is known to induce aberrations in brain development and stress sensit...

Detailed Description

Introduction: Multiple Sclerosis (MS) affects 1 in 1,000 people in industrialised countries, mainly women of childbearing age. To prevent MS relapses, most patients receive disease-modifying therapies...

Eligibility Criteria

Inclusion

  • MS diagnosis was made based on the McDonald criteria valid at the time of diagnosis
  • Written consent by the legal guardians of the participating child following a detailed oral and written education
  • Exposed group (n=40): Children and adolescents (aged 8 to 18 years) of mothers with prenatal exposition to MP in the context of a MS relapse therapy
  • Non-exposed group (n=40): Children and adolescents of mothers suffering from MS without MP therapy during pregnancy (aged 8 to 18 years) matched for age, gender and social background

Exclusion

  • Perinatal complications such as cerebral bleeding, neonatal intensive care with ventilation, prenatal therapy with glucocorticoids except for an MS relapse
  • Maternal abuse of noxious agents during pregnancy
  • Long-term glucocorticoid medication (e.g. asthma)
  • Preterm births (before 36 weeks of pregnancy)
  • Severe disease making an examination impossible (e.g. mental retardation)
  • disease-modifying therapy during pregnancy

Key Trial Info

Start Date :

October 19 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT04832269

Start Date

October 19 2020

End Date

December 31 2024

Last Update

March 6 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Ruhr University of Bochum

Bochum, Germany, 44791

2

University Hospital Jena

Jena, Germany, 07747